Schrödinger Highlights Progress of Clinical Programs and Discloses Three New Programs at First Therapeutics Pipeline Investor Event

14.12.2023 - Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, is providing a detailed review of its proprietary drug discovery and development programs during its Pipeline ... Seite 1

Related Keywords

United States ,American ,Margaret Dugan ,American Society Of Hematology Annual Meeting ,Pipeline Day ,American Society ,Hematology Annual ,Schrodinger Chart ,Chrodinger Kurs ,Chrodinger Aktie ,